Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
38%
Ph phase_3
1
13%
Ph not_applicable
2
25%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(2)

Detailed Status

Completed4
unknown2
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (25.0%)
Phase 23 (37.5%)
Phase 31 (12.5%)
N/A2 (25.0%)

Trials by Status

unknown225%
completed450%
withdrawn113%
active_not_recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
active_not_recruitingnot_applicable

Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

NCT07366710
withdrawnphase_1

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

NCT04885491
unknownphase_2

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

NCT05699486
completedphase_1

A First-in-Human Study to Assess the Safety and Tolerability of PDNO

NCT04891354
completednot_applicable

Iron Status and Human Metabolism

NCT02308449
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07366710Not Applicable

Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET

Active Not Recruiting
NCT04885491Phase 1

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in COVID-19 Patients With Acute Pulmonary Hypertension

Withdrawn
NCT05699486Phase 2

A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery

Unknown
NCT04891354Phase 1

A First-in-Human Study to Assess the Safety and Tolerability of PDNO

Completed
NCT02308449Not Applicable

Iron Status and Human Metabolism

Completed
NCT01584453Phase 2

Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction

Completed
NCT01459419Phase 2

Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

Unknown
NCT00524381Phase 3

Etanercept Treatment in the Early Course of Polymyalgia Rheumatica

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8